Discordant results on body fluid levels of human chorionic gonadotrophin (hCG) free \g=a\-and \g=b\-subunits under physiological and pathophysiological conditions, prompted us to raise a total of 260 monoclonal antibodies (MCA) against free hCG-\g=a\,free hCG-\g=b\, holo-hCG, human follicle-stimulating hormone and bovine luteinizing hormone; 153 MCA recognizing the human \g=a\-subunit and 28 reacting with hCG-\g=b\ were extensively analysed for their intra-and interspecies cross-reactivity with homologous hormones, and for the compatibility of epitopes recognized by them. The immunological topography of free hCG-\g=a\ and free hCG-\g=b\ was resolved by these MCA, and epitope maps were designed. Six antigenic determinants on the free \g=a\-chain ( \ g=a\ 1\ p=n-\ \ g=a\ 6) , clustered in three spatially distinct domains, and seven epitopes on the surface of free hCG-\g=b\( \ g=b\ 1\ p=n-\ \ g=b\ 7) , could be distinguished.
INTRODUCTION
Each of the four phylogenetically, biochemically and immunologically closely related human glycoprotein hormones: chorionic gonadotrophin (hCG), luteiniz¬ ing hormone (LH), follicle-stimulating hormone (FSH) and thyrotrophin (TSH), is composed of two noncovalently linked subunits designated and ß. These are separately encoded by at least ten genes (Boothby, Ruddon, Anderson et al. 1981; Hayashizaki, Miyai, Kato & Matsubara, 1985; Policastro, Daniels- McQueen, Carle & Boime, 1986; Watkins, Eddy, Beck et al. 1987) . Within a given species, only a single gene exists for the a-subunit which all members of this family have in common. It is therefore the hormonespecific ß-chain that determines the biological and antigenic specificity (for review see Ryan, Keutmann, Charlesworth et al. 1987 ). The trophic roles of the holohormones have long been recognized, whereas the physiological importance and even levels in body fluids of their free subunits are still a matter of debate (Hay, 1985; Ozturk, Bellet, Manil et al. 1987; Whitcomb, Sangha, Schneyer & Crowley, 1988) . This is mainly due to the incomplete knowledge of their antigenic proper¬ ties and, in consequence, lack of specific and sensitive assay systems. Based on antigenic surface descriptions of the four holo-hormones (Schwarz, Berger & Wick, 1986; Berger, Panmoung, Khaschabi et al. 1988; Schwarz, Berger, Nelböck et al. 1988 ), the present study aimed to define the immunological maps of hCG-a and hCG-ß by monoclonal antibodies (MCA), providing a basis for investigations on hormonal structure-function relationships and the establishment of improved epitope-selective immunoenzymometric assays (IEMA) for the free hCG subunits.
MATERIALS AND METHODS

Monoclonal antibodies
Monoclonal antibodies against bovine (b) LH (NIH-LH-B9), hCG and free hCG-ß (Pregnyl; Organon, Oss, The Netherlands), free hCG-a (PAA-Laborgesellschaft m.b.H., Gallneukirchen, Austria) and hFSH (Boehringer Mannheim GmbH, F.R.G. andlmmunex, San Diego, CA, U.S.A.) were produced as described in detail elsewhere (Kofler, Kalchschmid, Berger & Wick, 1981; Kofler, Berger & Wick, 1982; Bergere? al. 1988 Immunoenzymometric assay for the free a-subunit ELISA-plates were coated with a MCA, designated INN(sbruck)-hCG-72, which is specific for the free asubunit (50 pg MCA/ml PBS; 100 pi, 16h, 4°C). Blocking, extensive washing and the antigen incu¬ bation with hCG-a was performed as described above. The second peroxidase-labelled MCA (INNhFSH-158) was diluted to 10pg/ml in 1% BSA/PBS and incubated for 30 min at 37°C (100 pi/ well). 3,3',5,5'-Tetramethylbenzidine (TMB; 6 mg; Boehringer Mannheim GmbH) was dissolved in 1 ml dimethylsulphoxide (Sigma). Immediately before use, this stock solution was diluted to 100 pg TMB/ml in 0-1 mol sodium acetate buffer/1 (ph 5-5) and 1-3 mmol H202/1. The substrate reaction was terminated after 30 min by addition of 50 pi H2S04 (1 mol/1) per well and the results read at 450 nm. In order to achieve higher sensitivity and stability of the IEMA, the capture as well as the detection MCA were purified by high-pressure liquid chromatography (HPLC) according to the manufacturer's recommendations (Biorad, Richmond, VA, U.S.A.), using a preparative hydroxylapatite column. Purity was checked by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (Hoefer Scientific Instruments, CA, U.S.A.) on 14% gels (Laemmli, 1970) . The detection MCA was labelled to a higher specific activity as originally described for polyclonal antibodies by Wilson & Nakane (1978) using ultracentrifuged MCA (100 000#, 4 mg MCA/ ml), 12 mg peroxidase/ml, 0-2 mol Nal04 and 0-4 mol carbonate buffer/1. (Kofler, Berger 6 Wick, 1982) , free hCG-a, hLH, hTSH, hFSH ) and, for control purposes, with an antibody against human prolactin (Staindl, Berger, Kofler & Wick, 1987) . HPLC-purified or ammonium sulphate-precipitated ascites-derived MCA (approxi¬ mately 50 pg/ml) were incubated for 2 h on an automatic shaker with 1 ml goat IgG-anti-mouse Ig coupled to cyanogen bromide-activated Sepharose 6B beads (Pharmacia Fine Chemicals) prepared accord¬ ing to the method of Cuatrecasas (1970) . After exten¬ sive washing with 1% BSA/PBS, the MCA-coated beads were resuspended in equal volumes of hormone solutions (up to 1 pg/ml) and incubated for 2 h. After centrifugation, the supernatant was withdrawn and the absorption procedure repeated twice with fresh MCA-coated beads. The purified standards were measured in the free a-subunit as well as in respective holo-hormone assays.
RESULTS
Monoclonal antibodies
A total of 260 MCA-secreting cloned hybridoma cell lines were established (designated INN-hCG-1 to 82, INN-hFSH-1 to 181 and INN-bLH-1 to 5), some of which have been described previously (Kofler et al. 1981 (Kofler et al. , 1982 (Fig. 2) . MCA against the ß-subunit were specific for hCG and hCG-ß (group ß,), or cross-reacted with hLH (ßj), or additionally recognized LH of various species (ß3, ß4 and ß5) or specifically distinguished free hCG-ß-subunits from holo-hCG and holo-hLH (ß6 and ß7). The antibodies against the -chain were classified as (i) reacting with all human a-subunits and holo-hCG (a,, a2 and a3), (ii) displaying interspecies cross-reactivity (a4, a5 and a6) and (iii) recognizing only free a-subunit but not holo-hCG (a6). approach (e.g. a2 and a,, a4 and a5, ß3 and ß4) and/or by differences in interspecies epitope sharing (e.g. ß, and ß4, ß3 and ß5) (see Fig. 2 ).
Epitope maps for free -subunit and free hCG-ß
Monoclonal antibodies with identical specificity in one-and two-site RIA and ELISA were assigned to groups, designated ,-6 and ß,-ß7, which were defined to represent single epitopes. Topographical epitope arrangement was resolved by sandwich ELISA (Fig. 2) . Spatial disparity of antigenic deter- (Fig.  3) . A summary of epitope characteristics is given in Table 2 .
Immunoenzymometric assay for the free a-subunit A two-step sandwich assay design was chosen for the measurement of free -subunit (Fig. 4) •Levels of hCG-a could be measured in large excess of holo-hormones; tbeginning of polychemotherapy.
7-3% (coefficient of variation) at a dose level of 1 -6 pg/ well to 1 -4% at 500 pg/well; between-assay precision was 9-7%. Pregnancy sera revealed parallel responses to the standard on dilution, and recovery of hCG-a from serum was 103%. Apparent cross-reactivity with holo-hCG was less than 0-005%, and between 0-2 and 0-4% for the three pituitary hormones hLH, hFSH and hTSH, which might be due to contamination by free -subunit in these standard preparations (Fig. 4) . (Hussa 1981; Hay 1985; Schwarz, Berger & Wick, 1985; Ozturkera/. 1987; Whitcomb et al. 1988) . Reliable data are scarce regarding the site of pro¬ duction, the levels under various physiological and pathophysiological conditions and the biological sig¬ nificance of free a-and ß-subunits. Attempts to clarify the situation by the production of a-chain-specific MCA have been published previously (Stuart, Underwood, Harman et al. 1983 ; Thotakura & Bahl, 1985; Norman, Haneef, Buck & Joubert, 1987; Ozturk et al. 1987; Bidart, Troalen, Bousfield et al. 1988 ).
The production and characterization of a large number (260) of MCA against human and animal glycoprotein hormones and hormone subunits enabled us to map immunologically the antigenic sur¬ face of the free a-and the free hCG-ß-subunit, and to design models of their immunological structure. On this basis we were able to establish an epitope-selective IEMA that is more specific and sensitive for the free -subunit than previously published assays (Table 4) .
Our reference values for free -subunit in the serum of Kim & Chappel, 1984) . The differences might be due to the fact that either RIA with polyclonal antisera (Snyder et al. 1984; Ishibashi, Yamaji, Takaku et al. 1987) or immunoradiometric assay with MCA of limited specificity (Norman et al. 1987 ) and sensitivity (Ozturk et Table 4) .
From an immunological point of view, the free asubunit of the human glycoprotein hormones bears at least six antigenic determinants arranged in three spatially independent domains. Attention should be focused on the fact that interspecies epitope sharing could be observed for three determinants, including the epitope a6 which is unique for the free a-subunit. Interestingly, the three epitopes which are shared between various species are not confined to a particu¬ lar antigenic domain. These findings challenge the concept proposed by Vaitukaitis, Ross, Reichert & Ward (1972) declaring a-subunits as immunologically species specific. As expected, no intraspecies distinc¬ tion of a-subunits derived from hLH, hFSH and hTSH was possible by our MCA. In addition to these a-epitopes, so-called c-epitopes which are expressed only on the surface of structural integer aß dimers might be located on the -chain having undergone a conformational change upon subunit assembly as pre¬ viously suggested for hFSH (Hojo & Ryan, 1985) and hCG (Schwarz et al. 1986 ). The inverse could be true for the free a-epitope (a6), i.e. disappearance of this determinant, not by masking of a subunit-subunit interaction site in the holo-hormone, but by a con¬ formational change of the -subunit upon association with the ß-chain. On the other hand, it is tempting to speculate that the a6-epitope could be formed by the COOH-terminal region of the protein backbone, which has been shown to be inaccessible to antibody in the holo-hormone (Troalen, Bellet, Giuliani et al. 1988 ). Moreover, the COOH-terminal portion of the -chain is not glycosilated, and it was previously demonstrated that none of the epitopes on free hCGa and free hCG-ß is associated with molecular variants which differ in their carbohydrate structures (Mann, Spöttl, Berger et al. 1988 ).
In contrast to the free -subunit, the free hCG-ß chain expresses seven determinants which apparently conflue to a single large domain. Three epitopes (ß,, ß2 and ß3) have been described previously (Schwarz et al. 1986 ). Immunogenicity of the hCG-ß chain seems to be very much restricted to the free ß-core fragment as all ß-MCA, including the free ß-determinants ß6 and ß7 and the hCG-specific epitope ß2 recognize it. It is noteworthy that, despite extensive intra-and inter¬ species LH-ß and CG-ß amino acid sequence homologies (for review see Ryan et al. 1987) , three out of seven epitopes (ß2, ß6 and ß7) are species specific, including the two specific determinants of free hCG-ß, ß6 and ß7; two determinants (ß2 and ß7) are also hor¬ mone specific, although they are not located on the COOH-terminal peptide, which is unique for hCG-ß.
